A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)
A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)
Not yet recruiting · NCT07709000 · Registry updated 2026-10-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006) | B-cell chronic lymphocytic leukemia, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hematologic disorder, hematopoietic and lymphoid system neoplasm, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Not yet recruiting | Phase 2 | 2026-10-08 | NCT07709000 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merck Sharp & Dohme LLC | 650 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Haddasah Medical Center ( Site 0800) | Jerusalem | Israel | 1 |
| Rambam Health Care Campus ( Site 0803) | Haifa | Israel | 1 |
| Shaare Zedek Medical Center ( Site 0801) | Jerusalem | Israel | 1 |
| Sheba Medical Center ( Site 0802) | Ramat Gan | Israel | 1 |
| Sourasky Medical Center ( Site 0804) | Tel Aviv | Israel | 2 |